Action

BTK

Approval Jurisdiction

2013 FDA 2013 EMA

Approved for clinical use

Mantle cell lymphoma

Brutto

CAS

936563-96-1

Commercial Vendor

Janssen Pharmacyclic

Compound Image

Ibrutinib.png

Compound name

Ibrutinib

InChI

InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1

InChI Key

XYFPWWZEPKGCCK-GOSISDBHSA-N

MW

440.50

PubChem CID

24821094

Reference

Reference 2

SMILES

C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N

Approved Drug List

1